Skip to content

    Caris Life Sciences (CAI) stock price & financials

    View CAI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance32.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $100.05M
    $101.62M
    $120.92M
    $181.40M
    $216.83M
    +116.7%
    $292.89M
    +188.2%
    $216.17M
    +78.8%
    $263.71M
    +45.4%
    Strengthening
    Operating Profit
    -$67.01M
    -$60.84M
    -$57.95M
    -$17.99M
    $32.64M
    $88.41M
    $5.28M
    $26.93M
    Weakening
    Net Profit
    -$66.19M
    -$67.73M
    -$102.58M
    -$71.79M
    $24.32M
    $81.96M
    -$510.0K
    +99.5%
    -$637.0K
    +99.1%
    Strengthening
    EPS
    $-2.54
    $-2.59
    $-3.57
    $-7.97
    $0.09
    $0.00
    +100.0%
    $0.00
    +100.0%
    Strengthening
    Other Income
    $825.0K
    -$6.89M
    -$44.63M
    -$53.80M
    -$8.32M
    -1108.1%
    -$6.45M
    +6.3%
    -$5.93M
    +86.7%
    -$27.54M
    +48.8%
    Strengthening
    Interest
    $13.67M
    $13.80M
    $12.78M
    $19.21M
    $13.51M
    -1.2%
    $11.36M
    -17.7%
    $12.81M
    +0.2%
    $9.23M
    -52.0%
    Weakening
    Depreciation
    Profit before Tax
    -$66.19M
    -$67.73M
    -$102.58M
    -$71.79M
    $24.32M
    $81.96M
    -$644.0K
    +99.4%
    -$614.0K
    +99.1%
    Strengthening
    MarginsOPM
    -67.0%
    -59.9%
    -47.9%
    -9.9%
    15.1%
    30.2%
    2.4%
    10.2%
    Weakening
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    20.8%
    -3.8%
    ReturnsROIC
    2.5%
    2.6%
    3.9%
    2.7%
    -0.9%
    -136.8%
    -3.1%
    -221.0%
    0.0%
    -99.5%
    0.0%
    -99.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY23FY24FY25TTM
    AssetsCash & Equivalents$63.95M$796.27M
    Short-Term Investments$2.20M$2.29M$102.20M
    Total Current Assets$215.73M$997.80M$1.06B
    Net PP&E$102.77M$103.02M$95.72M
    Goodwill$19.34M$19.34M$19.34M
    Intangibles
    Total Assets$343.73M$1.13B$1.23B
    LiabilitiesTotal Current Liabilities$165.42M$127.14M$191.44M
    Short-Term Debt$60.09M$169.0K$178.0K
    Long-Term Debt$319.44M$378.82M$392.97M
    Long-Term Leases$38.65M$42.34M$52.88M
    Total Liabilities$620.92M$548.36M$637.89M
    EquityCommon Stock & APIC$38.0K$283.0K$283.0K
    Retained Earnings-$2.47B-$2.55B-$2.55B
    Total Equity-$2.14B-$2.50B$577.31M$591.73M
    HighlightsNet Cash / (Debt)-$313.38M$419.58M-$290.95M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY23FY24FY25TTM
    ActivitiesCash from Operating-$276.10M-$245.20M$83.16M$168.56M
    Cash from Investing$214.77M$52.93M-$16.26M-$144.72M
    Cash from Financing$10.13M$200.29M$664.99M-$53.78M
    SummaryCapital Expenditure-$22.32M-$8.44M-$16.26M
    Free Cash Flow-$298.42M-$253.64M$66.89M
    FCF Margin-97.5%-61.5%8.2%

    Ratios